Roughly three to five out of every hundred people live with hyperhidrosis, a condition defined by sweating that exceeds what the body needs for temperature control. In the United States alone, surveys have placed the number between about 8 million and 15 million people, depending on the study and the decade it was conducted. Those figures make hyperhidrosis far more common than most people assume, yet it remains widely underdiagnosed and rarely discussed openly.
Prevalence in the United States
Two large surveys have anchored the American estimates. The first, published in 2004 using data from a demographically weighted national sample, found a prevalence of 2.8%, which at the time translated to roughly 7.8 million people. About half of that group reported that their armpits were the primary problem area, putting axillary hyperhidrosis at around 1.4% of the population.1PubMed. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey A later survey, published in 2016 with updated methodology, arrived at a higher figure: 4.8%, representing an estimated 15.3 million Americans.2PubMed Central. Hyperhidrosis: an update on prevalence and severity in the United States
The jump from 2.8% to 4.8% does not necessarily mean more people developed the condition between those two surveys. Differences in how the questions were asked, how sweating was defined, and what population responded can all shift the numbers. Still, even the lower estimate makes hyperhidrosis about as common as psoriasis, a skin condition most people have heard of. The gap between how common it is and how little public awareness it receives is one of the defining frustrations for people who have it.
How Estimates Vary Around the World
When researchers look beyond the United States, the range widens considerably. A targeted literature review published in 2023 found prevalence figures running from 2.8% in U.S. general-population studies up to 18.4% among Chinese inpatients. Axillary hyperhidrosis specifically ranged from 1.4% in U.S. surveys to about 5.75% in studies of Japanese employees and students.3PubMed. Hyperhidrosis: A targeted literature review of the disease burden Swedish data has placed overall prevalence at about 5.5%.4PubMed Central. ‘Excessive sweating is not a feminine thing’: A qualitative study of women’s experiences suffering from primary hyperhidrosis
Meanwhile, a Brazilian study that examined a random community sample found a prevalence of only about 0.93%.5PubMed Central. Hyperhidrosis: prevalence and impact on quality of life That figure is strikingly low compared with Western or East Asian estimates. Part of the reason is methodology: different studies use different thresholds for what counts as “excessive” sweating, and whether participants self-report or undergo a clinical exam makes a real difference. Cultural factors may also play a role in whether someone describes their sweating as a problem worth reporting at all.
The honest takeaway is that no single global prevalence number exists. Depending on the population studied and the criteria used, you can find estimates anywhere from under 1% to nearly 20%. Most researchers treat a ballpark of 3% to 5% as a reasonable middle ground for the general adult population in higher-income countries, while acknowledging that the true number may be higher because many people never seek care.
Who Gets Hyperhidrosis
Hyperhidrosis does not follow a simple demographic pattern. Population-level data suggests the condition is roughly equally common in men and women, though the experience of it can differ. A Swedish qualitative study noted equal prevalence across sexes.4PubMed Central. ‘Excessive sweating is not a feminine thing’: A qualitative study of women’s experiences suffering from primary hyperhidrosis In clinical settings, however, the picture can look different. A retrospective study of children and adolescents found that among younger age groups (ages six to eleven), girls were diagnosed far more often than boys. In the twelve-to-fourteen range, the split evened out, and in the oldest group studied (fifteen to seventeen), all diagnosed patients were boys.6PubMed Central. Primary Hyperhidrosis in Children—A Retrospective Study and a Short Review
Those findings probably reflect differences in when and why families seek help rather than actual sex-linked differences in sweat gland activity. Parents of younger girls may bring them to a doctor sooner due to social pressures, while adolescent boys with sweaty palms or feet may be more likely to raise the issue themselves as they enter their mid-teens. Either way, hyperhidrosis often starts in childhood or adolescence and can persist for decades if untreated.
Primary Versus Secondary Hyperhidrosis
The condition splits into two categories. Primary hyperhidrosis is the kind most people have. It starts on its own, tends to be focal (affecting specific body areas), and is not caused by an underlying medical condition. In one clinical study of over 400 patients evaluated for excessive sweating, about 93% had primary hyperhidrosis and roughly 7% had the secondary type.7PubMed. Clinical differentiation of primary from secondary hyperhidrosis
Secondary hyperhidrosis, by contrast, develops because of something else: a medication side effect, a hormonal shift such as menopause or hyperthyroidism, an infection, or a neurological condition. The sweating in secondary cases tends to be more generalized, often affecting the whole body rather than just the palms or armpits, and it usually resolves or improves when the underlying cause is addressed. This distinction matters for treatment. If you are sweating heavily all over your body and the problem started suddenly in adulthood, the cause may not be primary hyperhidrosis at all, and the appropriate first step is investigating what else might be going on.
Which Body Sites Are Most Common
Primary hyperhidrosis gravitates toward a few predictable areas. The hands, armpits, feet, and face account for the vast majority of cases.8PubMed Central. Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin In a Canadian review of clinical data, armpits were the most commonly affected site at about 51%, followed by feet at 29%, palms at 25%, and the face at 20%.9CMAJ. Focal hyperhidrosis: diagnosis and management Many people have more than one affected area, which is why those percentages add up to well over 100%.
The functional impact varies by site. Palmar hyperhidrosis can make simple tasks like writing, using a phone, or shaking hands genuinely difficult. Axillary hyperhidrosis creates visible sweat marks on clothing that affect professional and social confidence. Plantar (foot) hyperhidrosis contributes to slipping in shoes and raises the risk of fungal skin infections. Facial sweating is perhaps the hardest to conceal, and it often makes public speaking or eating in warm settings deeply uncomfortable.
Less commonly affected areas include the groin, the trunk, and the scalp. These are often grouped under “uncommon sites” in the medical literature, but for the people who have sweating in those areas, the quality-of-life burden is just as real.
A Genetic Thread
Primary hyperhidrosis runs in families. In a study of patients with palmar hyperhidrosis, 65% reported at least one family member with the same condition, compared with 0% of controls.10PubMed. Palmar hyperhidrosis: evidence of genetic transmission That same study found that about 28% of the children of affected individuals also developed the condition, far higher than the roughly 1% background rate in the general population. The inheritance pattern appears to be autosomal dominant with variable penetrance, meaning you only need to inherit one copy of the relevant gene variant to be at risk, but not everyone who carries it will develop noticeable symptoms.11PubMed Central. Primary hyperhidrosis: From a genetics point of view
This genetic component helps explain why many people with hyperhidrosis recall the condition starting in childhood and can point to a parent or sibling with the same problem. It also means that the trait does not appear to favor one sex over the other at the genetic level, even though the experience of seeking treatment can differ between men and women.
The Brain, Not the Sweat Glands
One common misconception is that people with hyperhidrosis have overactive or abnormal sweat glands. Research suggests the glands themselves are structurally and functionally normal. The dysfunction appears to lie in the central nervous system’s regulation of sweating: the signals that tell the glands to produce sweat are simply turned up too high or triggered too easily.12PubMed Central. Hyperhidrosis: A Central Nervous Dysfunction of Sweat Secretion
This matters for understanding treatment. Interventions that target the glands directly, such as Botox injections, work by blocking the chemical messenger that tells the gland to fire. Oral medications such as oxybutynin work by dampening the nerve signals more broadly. And surgical procedures like sympathectomy interrupt the sympathetic nerve chain that carries those signals. None of these approaches fix a broken gland, because the glands are not broken. They all aim to quiet the overactive control system.
Mental Health and Quality of Life
The psychological weight of hyperhidrosis is consistently heavier than outsiders expect. A large retrospective study comparing patients diagnosed with hyperhidrosis against matched controls found that about 41% of the hyperhidrosis group had depression or anxiety documented during follow-up, compared to roughly 28% of controls. After adjusting for other factors, the odds of depression or anxiety were about 76% higher in the hyperhidrosis group.13PubMed Central. Treatment Patterns, Depression, and Anxiety Among US Patients Diagnosed with Hyperhidrosis: A Retrospective Cohort Study
Smaller clinical studies paint an even starker picture. Among patients with severe sweating, half met criteria for social anxiety disorder, half for generalized anxiety, and nearly four in ten reported being anxious or depressed at baseline.14PubMed Central. The Impact of Hyperhidrosis on Quality of Life: A Review of the Literature Social avoidance is a recurring theme in qualitative research: people describe skipping social events, avoiding handshakes, wearing only dark or layered clothing, and carefully planning their activities around air-conditioned environments. The condition is not life-threatening, but it is life-shrinking in ways that can be hard to explain to someone who has never dealt with it.
Part of the problem is that hyperhidrosis is routinely dismissed as a cosmetic nuisance rather than a medical condition. That framing discourages people from seeking help, which in turn keeps the diagnosis rates low and the prevalence numbers artificially conservative. Many experts believe the true burden of the condition is substantially higher than any survey has captured.
Skin Infections and Physical Complications
Beyond the psychological toll, persistent moisture on the skin creates a physical one. A population-based study found that people with hyperhidrosis had a higher rate of antibiotic prescriptions, suggesting more frequent bacterial skin infections. Among those with a formal hospital diagnosis, the risk of being prescribed topical antifungal treatments was also elevated, about 43% higher than in matched controls.15PubMed. Hyperhidrosis and the risk of being treated for skin infections
Chronically damp skin, especially on the feet and in skin folds, provides an environment where bacteria and fungi thrive. People with plantar hyperhidrosis are particularly familiar with recurrent athlete’s foot, blistering, and maceration, where the skin softens and breaks down from prolonged moisture. Axillary hyperhidrosis can contribute to folliculitis and irritant dermatitis, especially when combined with frequent antiperspirant use or tight clothing. These complications are treatable, but they add to the cumulative burden that makes the condition much more than “just sweating a lot.”
The Workplace Cost
Hyperhidrosis does not stay in the bathroom or the bedroom; it follows people into their professional lives. A Japanese cost-of-illness study found that working patients with axillary hyperhidrosis reported about 30% overall work impairment, and full-time homemakers with the condition reported activity impairment approaching 50%.16PubMed Central. Cost‐of‐illness study for axillary hyperhidrosis in Japan A separate study looking specifically at palmar hyperhidrosis estimated a productivity decrease of about 7%, and noted that correcting that loss would more than cover the cost of regular treatment with botulinum toxin.17PubMed Central. Decreased work productivity due to primary palmar hyperhidrosis. What is the cost?
These numbers are hard to compare directly across countries because of differences in healthcare costs, wages, and survey methodology. But the direction is consistent: hyperhidrosis makes people less productive, more distracted, and more likely to avoid tasks or settings where their sweating would be visible. Jobs that involve handshaking, handling paper documents, touching electronics, or standing in front of a group become logistically and emotionally harder. Some people change career paths entirely to avoid these situations, a cost that no economic study fully captures.
Why the Numbers Are Probably Undercounted
Several forces push prevalence estimates downward. The most obvious is that many people with excessive sweating never see a doctor about it. They may not realize it is a diagnosable condition, may feel embarrassed raising it, or may have been told by a previous physician that it is “just stress.” Studies that rely on clinical diagnoses or insurance claims will inevitably miss these individuals.
Survey-based studies capture more cases but depend on the participant recognizing that their sweating is abnormal. Someone who has sweated heavily since childhood may have no reference point for what normal sweating feels like, and may therefore not report it. Cultural attitudes toward sweating also vary. In some populations, heavy sweating may be more normalized or less socially stigmatized, reducing the likelihood that it gets flagged as a medical problem in a survey.
There is also the question of severity thresholds. Mild hyperhidrosis, where the sweating is noticeable but does not significantly interfere with daily activities, may not be counted in studies that require functional impairment for a positive diagnosis. This explains some of the gap between the highest and lowest prevalence figures: the studies that cast the widest net, counting anyone who reports sweating more than they feel is normal, produce higher numbers than those that require clinical confirmation or demonstrated quality-of-life impact.
For all these reasons, the commonly cited range of 3% to 5% in the general adult population should be treated as a floor rather than a ceiling. The actual number of people whose lives are affected by excessive sweating, even mildly, is almost certainly higher.